Acumen Pharmaceuticals, Inc. (ABOS)

NASDAQ: ABOS · Real-Time Price · USD

2.460

-0.060 (-2.38%)

At close: Apr 28, 2026, 4:00 PM EDT

2.450

-0.010 (-0.41%)

After-hours: Apr 28, 2026, 4:39 PM EDT

Acumen Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2019
Cost of Revenue	104.89	93.8	42.32	32.36	12.31	Upgrade
Gross Profit	-104.89	-93.8	-42.32	-32.36	-12.31	Upgrade
Selling, General & Admin	18.95	20.22	18.82	12.88	7.28	Upgrade
Operating Expenses	18.95	20.22	18.82	12.88	7.28	Upgrade
Operating Income	-123.83	-114.02	-61.14	-45.24	-19.58	Upgrade
Interest Expense	-4.22	-4.07	-0.58	-	-	Upgrade
Interest & Investment Income	7.45	14.32	10.79	2.39	0.24	Upgrade
Other Non Operating Income (Expenses)	-0.73	1.44	-1.44	-0.01	-81.11	Upgrade
EBT Excluding Unusual Items	-121.34	-102.33	-52.37	-42.86	-100.45	Upgrade
Gain (Loss) on Sale of Investments	-	-	-	-	-0.16	Upgrade
Pretax Income	-121.34	-102.33	-52.37	-42.86	-100.61	Upgrade
Net Income	-121.34	-102.33	-52.37	-42.86	-100.61	Upgrade
Net Income to Common	-121.34	-102.33	-52.37	-42.86	-100.61	Upgrade
Shares Outstanding (Basic)	61	60	49	41	20	Upgrade
Shares Outstanding (Diluted)	61	60	49	41	20	Upgrade
Shares Change (YoY)	0.91%	23.46%	19.72%	102.43%	4685.59%	Upgrade
EPS (Basic)	-2.00	-1.71	-1.08	-1.06	-5.02	Upgrade
EPS (Diluted)	-2.00	-1.71	-1.08	-1.06	-5.02	Upgrade
Free Cash Flow	-115.63	-86.23	-43.09	-35.31	-18	Upgrade
Free Cash Flow Per Share	-1.91	-1.44	-0.89	-0.87	-0.90	Upgrade
EBITDA	-123.77	-113.95	-61.08	-45.21	-19.58	Upgrade
D&A For EBITDA	0.06	0.06	0.06	0.03	0	Upgrade
EBIT	-123.83	-114.02	-61.14	-45.24	-19.58	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.